Dan Bai Xiao Formula combined with glucocorticoids and cyclophosphamide for pediatric lupus nephritis: A pilot prospective study

doi:10.12998/wjcc.v10.i31.11391

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3332)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

148

WORD

HTML

1702

Figures (1-4)

375

Tables (1-4)

291

Sum=2556

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

208

Download

568

Sum=776

Nov 6, 2022 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Cases. Nov 6, 2022; 10(31): 11391-11402
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11391

Full Size Figure Download Figure

Figure 2 Comparison of complete remission between the two groups at week 24. A and B: Number of patients with complete remission and partial remission in the traditional Chinese medicine (TCM) and control groups at 24 wk; C and D: Total remission (complete and partial response) and treatment failure in the TCM and control groups at 24 wk. TCM: Traditional Chinese medicine.

Citation: Cao TT, Chen L, Zhen XF, Zhao GJ, Zhang HF, Hu Y. Dan Bai Xiao Formula combined with glucocorticoids and cyclophosphamide for pediatric lupus nephritis: A pilot prospective study. World J Clin Cases 2022; 10(31): 11391-11402
URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11391.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11391